AYURVEDIC MANAGEMENT OF GASTRO OESOPHAGEAL REFLUX DISEASE BY POLYHERBAL DRUG AND ITS RELATION TO ANXIETY AND DEPRESSION.

IMPACT OF ANXIETY UDVEGA AND DEPRESSION VISAD IN INDIVIDUAL WITH URDHAGA AMLAPITTA GASTRO OESOPHAGEAL REFLUX DISEASE AND ITS MANAGEMENT BY AYURVEDIC POLYHERBAL FORMULATION - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/112974

Enrollment

102

Registered

2026-06-18

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient with irrespective of sex. 2.Patient with a diagnosis of GERD and reports experiencing the frequency of eight main symptoms. Heart burn, food regurgitation, flatulence, belching, dysphagia, nausea, vomiting and acid regurgitation. 3.Having at least 2to 6 days of GER episode per week with heartburn and with or without regurgitation. 4.Patients not taking antacid or PPIs treatment for at least 2 weeks prior to initiation of intervention. 5.Patients with Anxiety in HAM-A Scale. mild to moderate anxiety severity score 18to 24. 6.Patients with depression in HAM-D Scale. mild to moderate depression score 8 to 23

Exclusion criteria

Exclusion criteria: Pregnancy, Gastro intestinal bleeding disorders, Erosive esophagitis, Barrett esophagus. Other Gastrointestinal disorders (Intestinal obstructive diseases, peptic ulcer, etc), Treatment resistance GERD, Psychiatric patients, patients under anxiety or depression medication, other severe organic diseases

Design outcomes

Primary

Measure	Time frame
The study aims to demonstrate that Ayurvedic management significantly reduces GERD symptoms and improves psychological well-being, validating the integrative approach in treating psychosomatic conditions like Urdhwaga Amlapitta. Timepoint: Before treatment After Treatment of 30 days, 60 days, 90 days.	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDR SATYASREE SUDIPTA MOHANTA

INSTITUTE OF POST GRADUATE AYURVEDIC EDUCATION AND RESEARCH AT SHYAMADAS VAIDYA SHASTRA PITH

drpartha264@gmail.com9433725917

Outcome results